ChemoMetec A/S/DKr CHEMM
07:00
09:00
11:00
12:55
14:55
1D1W1MYTD1Y5YMAX
About ChemoMetec A/S
ChemoMetec A/S is a biotechnology and life sciences company that specializes in the development, production, and sale of high-quality instruments for cell counting and analysis. Located in Denmark, the company serves various sectors, including research institutions, academic laboratories, and pharmaceutical companies. Its product portfolio includes advanced cell counters and analyzers, such as the NucleoCounter series, which are utilized for precise and reliable cell counting across multiple applications. Established in 1997, ChemoMetec has positioned itself through innovative technology that focuses on accuracy and ease of use. The company operates with a global reach, serving customers through both direct sales and a network of distributors.
Ticker
DKr CHEMM
Sector
Primary listing
CSE
Employees
172
Headquarters
Allerød, Denmark
Website
ChemoMetec A/S Metrics
BasicAdvanced
kr 6.6bn
37.21
kr 10.17
1.34
kr 7.00
1.85%
Price and volume
Market cap
kr 6.6bn
Beta
1.34
52-week high
kr 804.00
52-week low
kr 235.20
Average daily volume
80k
Dividend rate
kr 7.00
Financial strength
Current ratio
3.93
Quick ratio
3.023
Long term debt to equity
0.438
Total debt to equity
0.799
Dividend payout ratio (TTM)
68.81%
Interest coverage (TTM)
172.83%
Profitability
EBITDA (TTM)
244.162
Gross margin (TTM)
95.54%
Net profit margin (TTM)
35.90%
Operating margin (TTM)
46.86%
Effective tax rate (TTM)
22.58%
Revenue per employee (TTM)
kr 2,870,000
Management effectiveness
Return on assets (TTM)
19.08%
Return on equity (TTM)
28.31%
Valuation
Price to earnings (TTM)
37.207
Price to revenue (TTM)
13.355
Price to book
10.07
Price to tangible book (TTM)
13.56
Price to free cash flow (TTM)
45.62
Free cash flow yield (TTM)
2.19%
Free cash flow per share (TTM)
8.295
Dividend yield (TTM)
1.85%
Forward dividend yield
1.85%
Growth
Revenue change (TTM)
7.31%
Earnings per share change (TTM)
4.62%
3-year revenue growth (CAGR)
2.25%
10-year revenue growth (CAGR)
20.67%
3-year earnings per share growth (CAGR)
-0.48%
10-year earnings per share growth (CAGR)
28.72%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
No upcoming events
FAQs